FDA greenlights VIZZ, the first daily eye drops to restore near vision for adults with age-related blurry vision ...

LENZ Therapeutics recently received FDA approval for its Vizz eye drops to treat presbyopia in adults, offering a new non-surgical solution for age-related farsightedness. This regulatory milestone ...

A California company has created a first-of-its-kind eyedrop that corrects a certain type of vision impairment and could ...

Reading glasses might be the next thing to go the way of the flip phone. The FDA just approved VIZZ, a once-daily eye drop that helps you see up close without glasses. That’s a big deal if you’re over ...

The US FDA approval of Vizz was based on results from three randomised, double-masked, controlled Phase 3 studies.

Vizz being approved by the FDA marks a step in the right direction for treating vision loss in an accessible way.

It is anticipated that Vizz, manufactured by Lenz Therapeutics, will become commercially available in the US by the end of ...

Lenz Therapeutics has received approval from the Food and Drug Administration for Vizz (aceclidine ophthalmic solution) 1.44% ...

The US Food and Drug Administration has approved the first eye drop that can fix near vision, promising to help ...

Detailed price information for Lenz Therapeutics Inc (LENZ-Q) from The Globe and Mail including charting and trades.

Known as Vizz, the once-daily eye drops treat age-related blurry near vision — also known as presbyopia — for up to 10 hours at a time.